| Pathway
|
Tight Junction Assembly (Claudins)
|
|
Tight Junction Assembly (Occludin)
|
|
Adherens Junction Assembly (Cadherins)
|
|
Androgen Receptor to Beta-2-Microglobulin Signaling in Prostate Cancer
|
|
Androgen Receptor to FKBP5 Signaling in Prostate Cancer
|
|
Androgen Receptor to NKX-3.1 Signaling in Prostate Cancer
|
|
Androgen Receptor to Prostate Specific Antigen Signaling in Prostate Cancer
|
|
Kruppel-like Factor 6 Signaling in Prostate Cancer
|
|
Beta-Catenin to Androgen Receptor Signaling in Prostate Cancer
|
|
RNase L Signaling in Prostate Cancer
|
|
Androgen Receptor to c-Met Signaling in Prostate Cancer
|
|
Fatty Acid Synthase Signaling in Prostate Cancer
|
|
FOXM1 Signaling in Prostate Cancer
|
|
Androgen Receptor to GJB1 Signaling in Prostate Cancer
|
|
Androgen Receptor to Akt Signaling in Prostate Cancer
|
|
Prostate Cancer Overview
|
|
Metastatic Colorectal Cancer Overview
|
|
Myostatin-IGF1 Crosstalk in Skeletal Muscles
|
|
Dystrophin Glycoprotein Complex Signaling in Duchenne Muscular Dystrophy
|
|
IGF1 in Muscle Hypertrophy
|
|
Mechanism of Cetuximab Resistance in Colorectal Cancer
|
|
Nuclear EGFR
|
|
RARA Signaling Pathway in Acute Myeloid Leukemia (M3)
|
|
Block of Differentiation in Acute Myeloid Leukemia
|
|
Acute Myeloid Leukemia Overview
|
|
Alzheimer's Disease Overview
|
|
Notch Pathway in Multiple Myeloma Plasma Cells
|
|
TNFR to NF-kB Classical Pathway in Multiple Myeloma Plasma Cells
|
|
TNFR to NF-kB Alternative Pathway in Multiple Myeloma Plasma Cells
|
|
IL-6/IGF-1/VEGFA in Multiple Myeloma
|
|
Multiple Myeloma Overview
|
|
Chronic Myeloid Leukemia Overview
|
|
Genetic Rearrangements Involved in T-cell Acute Lymphoblastic Leukemia Development
|
|
B-cell Acute Lymphoblastic Leukemia Overview
|
|
T-cell Acute Lymphoblastic Leukemia Overview
|
|
B-cell Chronic Lymphocytic Leukemia Overview
|
|
GLIS3 Targets Possibly Involved in Thyroid Dysgenesis
|
|
Hodgkin Lymphoma Overview
|
|
Diffuse Large-B-cell Lymphoma, ABC Subtype
|
|
Diffuse Large-B-cell Lymphoma, GCB Subtype
|
|
Diffuse Large-B-cell Lymphoma, PMBL Subtype
|
|
Diffuse Large-B-cell Lymphoma Overview
|
|
Follicular Lymphoma Overview
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
|
Cowden Syndrome
|
|
Li-Fraumeni Syndrome
|
|
Interleukin-22 Induced Keratinocyte Proliferation in Psoriasis
|
|
Interleukin-17 Signaling in Psoriatic Keratinocytes
|
|
Mantle Cell Lymphoma Overview
|
|
PI3K/AKT/MTOR, NF-kB and BCR Signaling Deregulation in Mantle Cell Lymphoma
|
|
Canonical WNT Signaling in Mantle Cell Lymphoma
|
|
Hedgehog Signaling in Mantle Cell Lymphoma
|
|
Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Overview
|
|
Splenic Marginal Zone Lymphoma Overview
|
|
Breast Cancer Related to IGF1R/Akt Signaling Pathway
|
|
Breast Cancer Related to WNT Signaling Pathway
|
|
Breast Cancer Related to ERBB/VEGFR/Akt Signaling Pathway
|
|
Breast Cancer Related to ESR1 Signaling Pathway
|
|
Breast Cancer Related to NOTCH1 Signaling Pathway
|
|
ESR1/ERBB-positive Luminal Breast Cancer
|
|
Basal Breast Cancer
|
|
Proliferative Diabetic Retinopathy
|
|
Congenital Hypothyroidism Due to Thyroid-Stimulating Hormone Resistance
|
|
Thyroid Dysfunction in Graves Disease
|
|
Common Non-genomic Effects of Thyroid Hormones
|
|
Primary Overt Hypothyroidism Overview
|
|
Clear Cell Ovarian Carcinoma
|
|
Mucinous Ovarian Carcinoma
|
|
High-grade Serous Ovarian Carcinoma
|
|
Endometrioid Ovarian Carcinoma
|
|
Ovarian Cancer Overview
|
|
Low-grade Serous Ovarian Carcinoma
|
|
Type I Endometrial Cancer (Endometrioid Endometrial Cancer)
|
|
Type II Endometrial Cancer (Clear-cell Endometrial Cancer and Papillary Serous Endometrial Cancer)
|
|
Endometrial Cancer Overview
|
|
WNT Signaling in Melanoma
|
|
CD8+ T-cell Activation
|
|
T-cell Receptor Signaling
|
|
Cancer Overview
|
|
Onset of Atopic Dermatitis
|
|
Impairment of BMP and TGF-beta Signaling in Familial and Idiopathic Pulmonary Arterial Hypertension
|
|
Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension
|
|
Smooth Muscle Cell Dysfunction in Pulmonary Arterial Hypertension
|
|
BMP2 Activates Canonical WNT Signaling in Pulmonary Artery Endothelial Cells
|
|
Primary Glioblastoma
|
|
Secondary Glioblastoma
|
|
Activation of Glioma Stem Cell Program
|
|
Ependymoma
|
|
Astrocytoma
|
|
Medulloblastoma Overview
|
|
CCR5 Signaling in Macrophages in HIV Type 1 Infection
|
|
Osteoarthritis Overview
|
|
Steroid-Induced Cataract
|
|
Impairment of EDN, NRG, NRTN, and GDNF/RET Signaling in Hirschsprung Disease
|
|
Mutations in Neurogenic Transcription Factor Genes in Hirschsprung Disease
|
|
Sonic Hedgehog Signaling in Neuroblastoma
|
|
Non-Hereditary Genetic Rearrangements in Neuroblastoma
|
|
Growth Factor Signaling in Neuroblastoma
|
|
PHOX2B-Associated Neuroblastoma
|
|
ALK-Associated Neuroblastoma
|
|
Neuroblastoma Overview
|
|
Growth Factor Signaling in Pancreatic Cancer
|
|
TP53 Signaling in Pancreatic Cancer
|
|
STK11 Signaling in Pancreatic Cancer
|
|
TGFBR Signaling in Pancreatic Cancer
|
|
Pancreatic Ductal Carcinoma
|
|
Pancreatic Neuroendocrine Tumors
|
|
FSH Action in Polycystic Ovary Syndrome
|
|
Block of Ovulation in Polycystic Ovary Syndrome
|
|
Polycystic Ovary Syndrome Overview
|
|
Peutz-Jeghers Syndrome Overview
|
|
TP53 Signaling in Hepatocellular Carcinoma
|
|
WNT/beta-Catenin Signaling in Hepatocellular Carcinoma
|
|
Growth Factor Signaling in Hepatocellular Carcinoma
|
|
NOTCH Signaling in Hepatocellular Carcinoma
|
|
Hepatocellular Carcinoma Overview
|
|
Osteoclast Activation in Gout
|
|
Synovial Fibroblast Proliferation in Rheumatoid Arthritis
|
|
Osteoclast Activation in Rheumatoid Arthritis
|
|
PTPN22 Involvement in Rheumatoid Arthritis
|
|
Renin-Angiotensin-Aldosterone System in Myocardial Ischemia
|
|
Clozapine-Induced Granulocytopenia
|
|
Tamoxifen-Induced Endometrial Cancer
|
|
ROS in Angiotensin-Mediated Cardiovascular Remodeling and Hypertrophy
|
|
Wnt signaling, canonical pathway
|
|
angiotensin II signaling pathway via AT1 receptor
|
|
protein kinase C (PKC) signaling pathway
|
|
altered p53 signaling pathway
|
|
vascular endothelial growth factor signaling pathway
|
|
integrin mediated signaling pathway
|
|
mitogen activated protein kinase signaling pathway
|
|
phosphatidylinositol 3-kinase-Akt signaling pathway
|
|
integrin mediated signaling pathway
|
|
phosphatidylinositol 3-kinase-Akt signaling pathway
|
|
epidermal growth factor/neuregulin signaling pathway
|
|
phosphatidylinositol 3-kinase-Akt signaling pathway
|